Previous Alzheimer's drug trials have failed not because the underlying science was unsound, but because trial participants were already symptomatic—they had already crossed the tipping point—making it too late for prevention-focused drugs to be effective.
causalpending
Speaker
Unidentified Speaker — What You Can Do to Prevent Alzheimer's | Lisa Genova | TED [twG4mr6Jov0]Evidence Quote
“We think this is why, to date, these kinds of drugs have failed in clinical trials -- not because the science wasn't sound, but because the people in these trials were already symptomatic. It was too late.”
Created: 8/11/2026, 1:47:51 AM
Your notes
Loading notes...